Arcus Biosciences, Inc.
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 cl…
Biotechnology
US, Hayward [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared Arcus Biosciences, Inc. (RCUS) to it's peer group.
Peer Group
BPMC MDGL KRYS PTCT APLS GPCR CGEM RLAY TCRX AVRO XFOR DAWN HEPA ICPT IMMX ICVX CNSP ANNX INZY ITOS ABOS
Compare Together
Loading...